China is the bigger Cannabidiol (CBD) Supplements market: $426 Mn against $96 Mn in 2023, about 4.4 times as large.
India grows faster: 19.8% a year, against 18.3%. The gap still grows from $330 Mn to $1.7 Bn by 2033.
Clinical research: 9 active trials in China, 2 in India.
| Measure |  China |  India |
|---|---|---|
| Market size, 2023 | $426 Mn | $96 Mn |
| Market size, 2033 projected | $2.3 Bn | $587 Mn |
| Growth a year (CAGR) | 18.3% | 19.8% |
| Money added, 2023–2033 | $1.9 Bn | $491 Mn |
| Share of the world market | 8% | 1.8% |
| Size rank of 24 countries | #2 | #12 |
| Market per person, 2023 | $0.30 | $0.07 |
| Active clinical trials | 9 | 2 |
| Full report | China report | India report |
Year by year, 2023 to 2033
China India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Cannabidiol (CBD) Supplements, China or India?
China is the bigger Cannabidiol (CBD) Supplements market: $426 Mn against $96 Mn in 2023, about 4.4 times as large.
Which grows faster in Cannabidiol (CBD) Supplements, China or India?
India grows faster: 19.8% a year, against 18.3%. The gap still grows from $330 Mn to $1.7 Bn by 2033.
More Cannabidiol (CBD) Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.